Early life stages of Pink salmon (Oncorhynchus gorbuscha) are at risk of exposure to the active ingredients of chemotherapeutant formulations (hydrogen peroxide [HP], azamethiphos [AZ], emamectin benzoate [EB], cypermethrin [CP] and deltamethrin [DM]) used to control sea lice in salmon aquaculture. LC50 values (95% con dence intervals) for acute 48-h water exposures in order of least to most toxic to seawater-adapted pink salmon fry were: mg/L), EB (1090EB ( [676-2006 µg/L), µg/L), ] µg/L), and DM (980 [640-1800] ng/L). In subchronic 10-d lethality sediment exposure tests, LC50 values (95% con dence intervals) in order of least to most toxic were: EB (2065 [1384-3720] µg/kg), µg/kg), and DM (1035DM ( [640-2000 ng/kg). Alterations in behaviour varied between chemicals; no chemical attracted pink salmon fry; sh avoided HP to a limited extent at 50 mg/L), as well as EB (300 µg/L), and AZ (50 µg/L). Signi cant concentration-dependent decreases in olfactory responsiveness to food extract were seen following AZ, CP and DM exposures that occurred at lower concentrations with longer exposure periods (10 µg/L, 0.5 µg/L and 100 ng/L thresholds at 168 h). Following 10-d sediment exposures, olfaction was only affected by CP exposure at 50 µg/kg. Signi cant decreases in swimming performance (Ucrit) occured for HP, AZ, CP and DM at concentrations as low as 100 mg/L, 10 µg/L, 2 µg/L and 200 ng/L, respectively. This study provides comprehensive data on the lethal and sublethal effects of aquaculture chemotherapeutant exposure in early life stage pink salmon.